Sigrid Therapeutics
PrivateLast Round
VC Round
Jan 7, 2026
Est. Valuation
$65.88M
Total Funding Raised
$8.4M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Sigrid Therapeutics is a biotechnology company that develops non-pharmaceutical therapies for metabolic diseases using its proprietary SiPore® technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sigrid Therapeutics Comparables
Compare Sigrid Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gelesis Holdings Inc. | 76% | |
| AltrixBio Inc. | 76% | |
| Allurion | 67% |
Sigrid Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 7, 2026 | ||||
| VC Round | Oct 31, 2023 | ||||
| VC Round | Jan 16, 2023 | ||||
| Series A | Nov 10, 2021 | ||||
| VC Round | Sep 5, 2019 | ||||
Grant | May 28, 2019 |
Key People
Founding team and executive leadership
Sigrid Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Axilium Capital | VC Round |
| Almi Invest AB | Grant |
| Joyance Partners | Series A, VC Round |
| Irrus Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2026
Grew 30% QoQ, from 27 to 35 employees.
- Jul 15, 2026
Grew 68% QoQ, from 19 to 32 employees.
Sigrid Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Sigrid Therapeutics's valuation, stock price, and market status.
Is Sigrid Therapeutics a public or private company?
Sigrid Therapeutics is a private company.
What is the current stock price of Sigrid Therapeutics?
Sigrid Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Sigrid Therapeutics worth (valuation)?
Valuation information for Sigrid Therapeutics is not publicly available.
Can I buy Sigrid Therapeutics stock?
Sigrid Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Sigrid Therapeutics's last funding round?
Sigrid Therapeutics's most recent funding round was Early Funding on January 7, 2026.
Who are the main investors in Sigrid Therapeutics?
Key investors in Sigrid Therapeutics include Joyance Partners.
Will Sigrid Therapeutics IPO soon?
No public IPO plans have been announced for Sigrid Therapeutics.
How can I track Sigrid Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sigrid Therapeutics's secondary market activity and sign up for updates.